HJ Science IPO: Late Move in Crowded Market Dampens Future Growth Prospect
HJ Science has launched its HK IPO consisting of 14M H shares at HK$81.80 per share to fund ongoing and planned R&D activities for pipeline...
HJ Science (华健未来) IPO: Analysis of Deal Terms
We analyze HJ Science IPO, which targets USD 143m. While valuation is demanding, deal momentum points to likely positive performance.
HJ Science (华健未来) Pre-IPO: Thoughts on Valuation
HJ Science is seeking to raise at least USD100m via a Hong Kong listing. We value the four pipeline assets at USD317m on a China SOTP basis.
HJ Science (华健未来) Pre-IPO: Clinical Evidence Needed for Pipeline Breadth
HJ Science passed the hearing for its HKEX Chapter 18A listing. HJ787 and HJ891 need cleaner pivotal data to justify pipeline breadth.
Aequitas ECM Weekly (22 June 2026) - SpaceX, GO, Lingyi, SG Micro, Circuit Fab, Merdeka, Kioxia, NSE
Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
No more insights